Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
A completed clinical trial studied clinical characteristics and prognostic factors in N2 non-small cell lung cancer patients. The study was …
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
An observational study investigating the clinical characteristics of patients with T1 non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
A completed clinical trial evaluating the effectiveness of sublobar dissection in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
A clinical trial update describes a study evaluating circulating tumor DNA detection to monitor patients after surgical treatment for non-sm…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Study in Non Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial in non-small cell lung cancer sponsored by Eli Lilly has completed, with results posted on May 18, 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating vinorelbine tartrate and paclitaxel in older patients with advanced non-small cell lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study evaluating MLN8237 in combination with erlotinib for non-small cell …
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of PX-866 and Docetaxel in Solid Tumors [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study of PX-866 with docetaxel in solid tumors, including non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC [Phase 1, Phase 2]
An early-phase clinical trial evaluating anti-MUC1 CAR T cells in combination with PD-1 knockout engineered T cells for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 safety and efficacy study evaluating the combination of CC-486 (oral azacitidine) with MK-3475 (pembrolizumab) in locally advanced…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
An observational, real-world study evaluating Avastin (bevacizumab) in elderly patients with non-squamous non-small cell lung cancer. The st…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung [NA]
Phase II study update on stereotactic body radiation therapy using Tomotherapy for lung tumors; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Lung Stereotactic Body Radiotherapy (SBRT) Delivered Over 4 Days Versus 11 Days [NA]
A completed trial compared delivering lung SBRT over 4 days with delivery over 11 days in patients with peripheral stage I non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating autologous immune killer cells in patients with late-stage non-small cell lung cancer and hepatocellular…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease [Phase 2]
Phase 2 trial update for advanced non-small cell lung cancer progressing after prior therapy; study terminated with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) [Phase 2]
Phase 2 trial evaluating metformin and carbohydrate restriction in combination with platinum-based chemotherapy for stage IIIB/IV non-squamo…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Concomitant Radio-chemotherapy in the Elderly [Phase 2]
A Phase 2 trial evaluating concomitant radiotherapy and chemotherapy in elderly patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This entry reports the completion of a Phase 1/2 clinical trial evaluating S-3304 in locally advanced non-small cell lung cancer. The study …
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC
Clinical trial update on prognostic value of tumor volume and its changes in radical radiotherapy for advanced non-small cell lung cancer.
-
FDA approval · 2018-04-30FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
The FDA approved Mylan Institutional LLC's original application for a generic docetaxel anhydrous product (ANDA208859).
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer [Phase 1]
A Phase 1 study evaluating varlilumab in combination with atezolizumab in patients with advanced cancers has been terminated.
-
CLINICAL_TRIALS research · 2018-04-30Clinical Trial Update: A Mobile Supportive Care App for Patients With Metastatic Lung Cancer [NA]
This document is a clinical trial update describing a study evaluating a mobile supportive care app for patients with metastatic non-small c…
-
CLINICAL_TRIALS withdrawal · 2018-04-30Clinical Trial Update: An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating BMS-986205 with nivolumab, with or without chemotherapy, versus chemotherapy in previously untreated stage IV or …
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Suction on Post-Operative Chest Tubes [NA]
The clinical trial evaluating suction on post-operative chest tubes in non-small cell lung cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating PT-112 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung c…